Taken together, our findings indicate that reduced CYFIP2 expression triggers a cascade of change towards Alzheimer’s disease, including amyloid production, tau hyperphosphorylation and memory loss. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.